EY US unveils Dr. Barry Patel and Dr. Wade Smith of Galt Companies as an Entrepreneur Of The Year® 2025 Southeast Award finalist ATLANTA, GA, UNITED STATES, April 28, 2025 /EINPresswire.com/ — Ernst & Young LLP (EY US) announced the finalists for the prestigious...
The Galt Franchise Model: What it Takes to Succeed and Why It’s Worth It!By Kevin Vora, Marketing and Business Development Starting a business from scratch can be daunting, but franchising offers a proven model that reduces risk while giving you the...
Galt’s decision was based on lessons offered by the pandemic, along with research showing an increase in productivity and creativity brought about by the 4-day workweek model. Galt Pharmaceuticals Co-founder and CEO Barry Patel/Courtesy of Galt Pharmaceuticals. Galt...
ATLANTA–(BUSINESS WIRE)–Galt Pharmaceuticals announced the acquisition of a specialty branded product from Fortovia Therapeutics. Effective December 2, 2020, Galt added Oravig®, the first and only orally-dissolving buccal tablet for oral thrush, to its growing...
ATLANTA–(BUSINESS WIRE)–Pharmaceutical innovator Galt Pharmaceuticals announced a new drug approval to offer a non-opioid, non-controlled, non-addictive alternative for healthcare providers to manage patients suffering from pain. On July 8, 2020 the U.S. Food and Drug...
We use cookies to ensure that we give you the best experience on our website. To understand how the cookies are being used, please see our Privacy Policy or click OK to continue.OkPrivacy policy
